Frazier Healthcare Partners

601 Union Street
Seattle, WA 98101

Website: frazierhealthcare.com

Firm Size

  • Assets Under Management (AUM):$4.7 Billion
  • Number of Funds:17
  • Employees:78
  • Firm Type:Private Equity
  • Focus Areas: Services
    Healthcare


Description

Frazier Healthcare Partners is a private equity firm based in Seattle, Washington, specializing in healthcare investments. Founded in 1991, the firm focuses on growth and buyout investments in the healthcare industry, targeting innovative companies across various sectors, including biopharma, medical devices, diagnostics, and healthcare services. With extensive domain expertise and a strong network in the healthcare sector, Frazier Healthcare Partners offers not only capital but also strategic guidance and operational support to its portfolio companies. The firm has a successful track record of partnering with management teams to help drive growth and create value in the companies it invests in. Frazier Healthcare Partners is committed to improving patient outcomes and delivering long-term value to its investors, while also making a positive impact on the healthcare industry as a whole.

Latest News

Powered by

Mar 12, 2024: GTCR Announces Sale of RevSpring
GTCR, a leading private equity firm, announced today that portfolio company RevSpring, Inc. ("RevSpring" or "the Company"), a leader in patient and consumer engagement and payment solutions, has been acquired by healthcare-focused investment firm Frazier Healthcare Partners.

Mar 12, 2024: Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
 Linden Capital Partners ("Linden"), a Chicago -based private equity firm focused exclusively on the healthcare industry, announced today the completion of its acquisition of Alcresta Therapeutics, Inc. ( "Alcresta"), a leader in commercializing novel enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases, from Athyrium Capital, Bessemer Venture Partners, Frazier Healthcare Partners, and HealthQuest Capital. HealthQuest Capital subsequently re-invested in Alcresta and will continue as a minority shareholder and board member.